{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:03:38Z","timestamp":1716509018922},"reference-count":192,"publisher":"Elsevier BV","issue":"5","content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.eimc.2013.12.003","type":"journal-article","created":{"date-parts":[[2014,1,29]],"date-time":"2014-01-29T16:00:39Z","timestamp":1391011239000},"page":"310.e1-310.e33","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Documento de consenso para el seguimiento de la infecci\u00f3n por el virus de la inmunodeficiencia humana en relaci\u00f3n con la reproducci\u00f3n, el embarazo, el parto y la profilaxis de la transmisi\u00f3n vertical del ni\u00f1o expuesto"],"prefix":"10.1016","volume":"32","member":"78","reference":[{"key":"10.1016\/j.eimc.2013.12.003_bib0005","unstructured":"Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1 Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States [consultado Ago 2012]. Disponible en: http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/PerinatalGL.pdf"},{"key":"10.1016\/j.eimc.2013.12.003_bib0010","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.fertnstert.2011.05.094","article-title":"Human immunodeficiency virus\/acquired immunodeficiency syndrome and infertility: Emerging problems in the era of highly active antiretrovirals","volume":"96","author":"Kushnir","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.eimc.2013.12.003_bib0015","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/01.aids.0000161776.30815.44","article-title":"Decreasing incidence of pregnancy by decreasing CD4 cell count in HIV-infected women in Cote d\u2019Ivoire: A 7-year cohort study","volume":"19","author":"Loko","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2013.12.003_bib0020","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1086\/323999","article-title":"Frequency of anovulation and early menopause among women enrolled in selected adult AIDS clinical trials group studies","volume":"184","author":"Clark","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2013.12.003_bib0025","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S1472-6483(10)60897-8","article-title":"Fertility assessment in non-infertile HIV-infected women and their partners","volume":"14","author":"Coll","year":"2007","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.eimc.2013.12.003_bib0030","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.fertnstert.2005.07.1326","article-title":"Human immunodeficiency virus infection and fertility care in the United Kingdom: Demand and supply","volume":"85","author":"Frodsham","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.eimc.2013.12.003_bib0035","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00002030-200401230-00018","article-title":"Pregnancy rates and predictors of conception, miscarriage and abortion in US women with HIV","volume":"18","author":"Massad","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2013.12.003_bib0040","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/01.aids.0000196161.25647.35","article-title":"Decreased pregnancy rate after in-vitro fertilization in HIV-infected women receiving HAART","volume":"20","author":"Coll","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2013.12.003_bib0045","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1177\/135965350801300607","article-title":"Mitochondrial DNA depletion in oocytes of HIV-infected antiretroviral-treated infertile women","volume":"13","author":"L\u00f3pez","year":"2008","journal-title":"Antivir Ther"},{"key":"10.1016\/j.eimc.2013.12.003_bib0050","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1093\/humrep\/17.8.2112","article-title":"Semen alterations in HIV-1 infected men","volume":"17","author":"Dulioust","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.eimc.2013.12.003_bib0055","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00404-011-1898-6","article-title":"HIV-infection and modern antiretroviral therapy impair sperm quality","volume":"284","author":"Kehl","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.eimc.2013.12.003_bib0060","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.fertnstert.2010.09.018","article-title":"HIV-positive patients undertaking ART have longer infertility histories than age-matched control subjects","volume":"95","author":"Santulli","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.eimc.2013.12.003_bib0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.fertnstert.2010.01.077","article-title":"Human immunodeficiency virus and infertility treatment","volume":"94","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.eimc.2013.12.003_bib0070","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.gyobfe.2011.07.029","article-title":"Assisted reproductive technologies in HIV patients: A comprehensive review of indications, techniques and results","volume":"39","author":"Gout","year":"2011","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.eimc.2013.12.003_bib0075","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0140-6736(05)61754-0","article-title":"Natural conception in HIV-negative women with HIV-infected partners","volume":"349","author":"Mandelbrot","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.eimc.2013.12.003_bib0080","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0140-6736(08)61115-0","article-title":"Relation between HIV viral load and infectiousness: A model-based analysis","volume":"372","author":"Wilson","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.eimc.2013.12.003_bib0085","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 infection with early antiretroviral therapy","volume":"365","author":"Cohen","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2013.12.003_bib0090","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/0140-6736(92)92495-2","article-title":"Insemination of HIV-negative women with processed semen of HIV-positive partners","volume":"340","author":"Semprini","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.eimc.2013.12.003_bib0095","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3109\/14647273.2010.495763","article-title":"A decade of the sperm-washing programme: Where are we now?","volume":"13","author":"Nicopoullos","year":"2010","journal-title":"Hum Fertil (Camb)"},{"key":"10.1016\/j.eimc.2013.12.003_bib0100","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.fertnstert.2008.04.013","article-title":"Providing fertility care to men seropositive for human immunodeficiency virus: Reviewing 10 years of experience and 420 consecutive cycles of in vitro fertilization and intracytoplasmic sperm injection","volume":"91","author":"Sauer","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.eimc.2013.12.003_bib0105","first-page":"CD008498","article-title":"Sperm washing to prevent HIV transmission from HIV-infected men but allowing conception in sero-discordant couples","author":"Eke","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eimc.2013.12.003_bib0110","doi-asserted-by":"crossref","first-page":"c2205","DOI":"10.1136\/bmj.c2205","article-title":"Combined antiretroviral treatment and heterosexual transmission of HIV-1: Cross sectional and prospective cohort study","volume":"340","author":"Del Romero","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.eimc.2013.12.003_bib0115","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/QAD.0b013e32832b7dca","article-title":"Sexual transmission of HIV according to viral load and antiretroviral therapy: Systematic review and meta-analysis","volume":"23","author":"Attia","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2013.12.003_bib0120","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/humrep\/dem226","article-title":"Is natural conception a valid option for HIV-serodiscordant couples?","volume":"22","author":"Barreiro","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.eimc.2013.12.003_bib0125","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1468-1293.2008.00634.x","article-title":"British HIV Association, BASHH and FSRH guidelines for the management of the sexual and reproductive health of people living with HIV infection 2008","volume":"9","author":"Fakoya","year":"2008","journal-title":"HIV Med"},{"key":"10.1016\/j.eimc.2013.12.003_bib0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/OLQ.0b013e318141fe9b","article-title":"Human immunodeficiency virus viral load in blood plasma and semen: Review and implications of empirical findings","volume":"35","author":"Kalichman","year":"2008","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.eimc.2013.12.003_bib0135","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1468-1293.2010.00868.x","article-title":"A decade of the sperm-washing programme: Correlation between markers of HIV and seminal parameters","volume":"12","author":"Nicopoullos","year":"2010","journal-title":"HIV Med"},{"key":"10.1016\/j.eimc.2013.12.003_bib0140","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1097\/QAD.0b013e32830abdc8","article-title":"Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma","volume":"22","author":"Marcelin","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2013.12.003_bib0145","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1097\/QAD.0b013e32834a36d0","article-title":"Pre-exposure prophylaxis and timed intercourse for HIV-discordant couples willing to conceive a child","volume":"25","author":"Vernazza","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2013.12.003_bib0150","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2011.02.026","article-title":"Achieving safe conception in HIV-discordant couples: The potential role of oral preexposure prophylaxis (PrEP) in the United States","volume":"204","author":"Lampe","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.eimc.2013.12.003_bib0155","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/aid.2010.0226","article-title":"Implications of HIV PrEP trials results","volume":"27","author":"Veronese","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.eimc.2013.12.003_bib0160","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/apc.2010.0222","article-title":"Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: Current considerations in light of new findings","volume":"25","author":"Myers","year":"2011","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.eimc.2013.12.003_bib0165","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1097\/QAD.0b013e32833bedeb","article-title":"Periconception pre-exposure prophylaxis to prevent HIV transmission: Benefits, risks, and challenges to implementation","volume":"24","author":"Matthews","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2013.12.003_bib0170","first-page":"586","article-title":"Interim Guidance for Clinicians Considering the Use of Preexposure Prophylaxis for the Prevention of HIV Infection in Heterosexually Active Adults","volume":"61","year":"2012","journal-title":"MMWR"},{"key":"10.1016\/j.eimc.2013.12.003_bib0175","series-title":"HIV\/AIDS Treatment and Care. Clinical Protocols for the WHO European Region","article-title":"Support for sexual and reproductive health in people living with HIV","year":"2007"},{"key":"10.1016\/j.eimc.2013.12.003_bib0180","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/sti.2003.007153","article-title":"Effectiveness of female controlled barrier methods in preventing sexually transmitted infections and HIV: Current evidence and future research directions","volume":"81","author":"Minnis","year":"2005","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.eimc.2013.12.003_bib0185","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0140-6736(02)11119-6","article-title":"Nonoxynol-9 fails to prevents STDs, but microbicide research continues","volume":"360","author":"Wilkinson","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.eimc.2013.12.003_bib0190","unstructured":"WHO. Medical eligibility criteria for contraceptive use. 4th edition. World Health Organization 2010 [consultado Jul 2012]. Disponible en: http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241563888_eng.pdf"},{"key":"10.1016\/j.eimc.2013.12.003_bib0195","unstructured":"WHO. Hormonal contraception and HIV. Technical statement. 16 February 2012 [consultado Jul 2012]. Disponible en: http:\/\/whqlibdoc.who.int\/hq\/2012\/WHO_RHR_12.08_eng.pdf"},{"issue":"Suppl 1","key":"10.1016\/j.eimc.2013.12.003_bib0200","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/01.aids.0000363778.58203.b6","article-title":"Safety of hormonal and intrauterine methods of contraception for women with HIV\/AIDS: A systematic review","volume":"23","author":"Curtis","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2013.12.003_bib0205","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2007.03.031","article-title":"A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus","volume":"197","author":"Stringer","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.eimc.2013.12.003_bib0210","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1742-6405-8-19","article-title":"Contraception in HIV-positive female adolescents","volume":"8","author":"Kancheva Landolt","year":"2011","journal-title":"AIDS Res Ther"},{"key":"10.1016\/j.eimc.2013.12.003_bib0215","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.contraception.2010.05.011","article-title":"IUD use in HIV-positive women","volume":"83","author":"Quinn","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.eimc.2013.12.003_bib0220","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0213-005X(01)72652-3","article-title":"Prevenci\u00f3n de la transmisi\u00f3n vertical y tratamiento de la infecci\u00f3n por VIH en la mujer embarazada. Recomendaciones de GESIDA-SEIMC, Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda (AEP), Plan Nacional sobre el Sida y Sociedad Espa\u00f1ola de Ginecolog\u00eda y Obstetricia (SEGO)","volume":"19","author":"Iribarren","year":"2001","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2013.12.003_bib0225","series-title":"Rapid HIV-1 Antibody Testing During Labor and Delivery for Women of Unknown HIV Status: A Practical Guide and Model Protocol","year":"2004"},{"key":"10.1016\/j.eimc.2013.12.003_bib0230","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1089\/apc.2009.0293","article-title":"Do HIV-infected women want to discuss reproductive plans with providers, and are those conversations occurring?","volume":"24","author":"Finocchario-Kessler","year":"2010","journal-title":"AIDS Patient Care STDS"},{"issue":"3 Suppl","key":"10.1016\/j.eimc.2013.12.003_bib0235","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.ajog.2007.03.087","article-title":"Recommendations for human immunodeficiency virus screening, prophylaxis, and treatment for pregnant women in the United States","volume":"197","author":"Jamieson","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.eimc.2013.12.003_bib0240","article-title":"Documento de Consenso de GeSida\/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (actualizaci\u00f3n enero 2011)","volume":"29","year":"2011","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2013.12.003_bib0245","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1086\/650005","article-title":"Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500copies\/ml at delivery: A case-control study nested in the French perinatal cohort (EPF-ANRS CO1)","volume":"50","author":"Tubiana","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2013.12.003_bib0250","series-title":"Antiretroviral pregnancy registry international interim report for 1 Jan 1989-31 Jan 2011","year":"2011"},{"key":"10.1016\/j.eimc.2013.12.003_bib0255","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1097\/QAD.0b013e32833a2a14","article-title":"Safety of efavirenz in first-trimester of pregnancy: A systematic review and meta-analysis of outcomes from observational cohorts","volume":"24","author":"Ford","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2013.12.003_bib0260","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1067\/S0002-9378(03)00467-8","article-title":"The relationship of pregnancy to human immunodeficiency virus disease progression","volume":"189","author":"Minkoff","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.eimc.2013.12.003_bib0265","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1097\/00002030-200012220-00013","article-title":"Combination antiretroviral therapy and duration of pregnancy","volume":"14","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2013.12.003_bib0270","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/01.aids.0000198090.70325.bd","article-title":"Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy","volume":"20","author":"Suy","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2013.12.003_bib0275","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/ajcn\/87.6.1639","article-title":"Nutritional indicators of adverse pregnancy outcomes and mother-to-child transmission of HIV among HIV-infected women","volume":"87","author":"Mehta","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.eimc.2013.12.003_bib0280","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1468-1293.2008.00619.x","article-title":"British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008","volume":"9","year":"2008","journal-title":"HIV Medicine"},{"key":"10.1016\/j.eimc.2013.12.003_bib0285","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/00002030-200403260-00012","article-title":"HIV-1 disease progression and fertility: The incidence of recognized pregnancy and pregnancy outcome in Uganda","volume":"18","author":"Ross","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2013.12.003_bib0290","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/01.qai.0000156854.99769.a5","article-title":"Does highly active antirretroviral therapy increase the risk of congenital abnormalities in HIV infected women?","volume":"40","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2013.12.003_bib0295","unstructured":"Gonzalez-Tome MI, Ramos J, Solis I, Mu\u00f1oz E, Guillen S, Almeda J, et al. Gestational diabetes and ART in pregnant HIV-1-infected women. 12th Conference on Retroviruses and Opportunistic Infections, February 2005, Boston, MA. [Abstract 68.]"},{"key":"10.1016\/j.eimc.2013.12.003_bib0300","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/01.aids.0000168973.59466.14","article-title":"Nelfinavir and nevirapine side effects during pregnancy","volume":"19","author":"Timmermans","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2013.12.003_bib0305","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/01.AOG.0000207657.94360.78","article-title":"Effect of protease inhibitor therapy on glucose intolerance in pregnancy","volume":"107","author":"Tang","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.eimc.2013.12.003_bib0310","doi-asserted-by":"crossref","first-page":"331.e1","DOI":"10.1016\/j.ajog.2006.11.037","article-title":"Protease inhibitor based antiretroviral therapy and glucose tolerance in pregnancy: AIDS Clinical Trials Group A5084","volume":"196","author":"Hitti","year":"2007","journal-title":"Am J Obstetr Gynecol"},{"key":"10.1016\/j.eimc.2013.12.003_bib0315","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1471-0528.1998.tb10227.x","article-title":"The association between maternal HIV infection and perinatal outcome: A systematic review of the literature and meta-analysis","volume":"105","author":"Brocklehurst","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.eimc.2013.12.003_bib0320","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1067\/mob.2002.123407","article-title":"Human immunodeficiency virus infection is a risk factor for adverse perinatal outcome","volume":"186","author":"Ellis","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.eimc.2013.12.003_bib0325","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00002030-200007070-00012","article-title":"Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine","volume":"14","author":"Lambert","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2013.12.003_bib0330","doi-asserted-by":"crossref","first-page":"F241","DOI":"10.1097\/00002030-199818000-00002","article-title":"Antiretroviral therapies in pregnancy: Maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study","volume":"12","author":"Lorenzi","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2013.12.003_bib0335","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1097\/00002030-200411190-00019","article-title":"Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe","volume":"18","author":"Thorne","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2013.12.003_bib0340","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1086\/503045","article-title":"Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth?","volume":"193","author":"Cotter","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2013.12.003_bib0345","doi-asserted-by":"crossref","first-page":"e900","DOI":"10.1542\/peds.2006-1123","article-title":"Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004","volume":"119","author":"Schulte","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.eimc.2013.12.003_bib0350","unstructured":"Gonz\u00e1lez-Tome MI, Cuadrado I, Mu\u00f1oz E, Prieto L, Soto B, Fraile B, et al. For the Spanish cohort of HIV mother to child transmission. Madrid. Spain. Risk factors of preterm delivery and low birth weight in a multicenter cohort of HIV-infected pregnant women. Abstract 744. CROI; 2011."},{"key":"10.1016\/j.eimc.2013.12.003_bib0355","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0301-2115(03)00153-2","article-title":"Pregnancy-related changes in the longer-term management of HIV-infected women in Europe","volume":"111","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.eimc.2013.12.003_bib0360","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/01.qai.0000139398.38236.4d","article-title":"Improved obstetric outcomes and few maternal toxicities are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancy","volume":"38","author":"Tuomala","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2013.12.003_bib0365","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/01.AOG.0000130066.75671.b2","article-title":"Does human immunodeficiency virus infection protect against preeclampsia-eclampsia?","volume":"104","author":"Frank","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.eimc.2013.12.003_bib0370","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejogrb.2004.04.014","article-title":"Preeclampsia and HIV infection","volume":"117","author":"Mattar","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.eimc.2013.12.003_bib0375","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S0140-6736(02)11195-0","article-title":"Pre-eclampsia, antiretroviral therapy, and immune reconstitution","volume":"360","author":"Wimalasundera","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.eimc.2013.12.003_bib0380","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/QAD.0b013e3282f2a939","article-title":"Maternal Herpes simplex virus type 2 infection, syphilis and risk of intra-partum transmission of HIV-1: Results of a case control study","volume":"22","author":"Cowan","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2013.12.003_bib0385","first-page":"1","volume":"58","author":"Kaplan","year":"2009","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.eimc.2013.12.003_bib0390","unstructured":"Panel on Antiretroviral Guidelines for Adult and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. January 10, 2011; 1-161 [consultado 25 Feb 2012]. Disponible en: http:\/\/aidsinfo.nih.gov\/contentfiles\/AdultandAdolescentGL.pdf"},{"issue":"2 Pt 1","key":"10.1016\/j.eimc.2013.12.003_bib0395","first-page":"451","article-title":"ACOG Practice Bulletin No. 101: Ultrasonography in pregnancy","volume":"113","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.eimc.2013.12.003_bib0400","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000318193","article-title":"First and second trimester markers of fetal aneuploidy in pregnant women with HIV infection","volume":"29","author":"Spencer","year":"2011","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.eimc.2013.12.003_bib0405","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1471-0528.2010.02767.x","article-title":"First-trimester markers of aneuploidy in women positive for HIV","volume":"118","author":"Savvidou","year":"2011","journal-title":"BJOG"},{"key":"10.1016\/j.eimc.2013.12.003_bib0410","unstructured":"Royal College of Obstetricians and Gynaecologists. Management of HIV in Pregnancy. Green Top Guideline n.\u00b0 39. June 2010."},{"issue":"Suppl 2","key":"10.1016\/j.eimc.2013.12.003_bib0415","first-page":"87","article-title":"British HIV Association guidelines for the management of HIV infection in pregnant women 2012","volume":"13","year":"2012","journal-title":"HIV Medicine"},{"key":"10.1016\/j.eimc.2013.12.003_bib0420","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1056\/NEJM199908053410602","article-title":"Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission","volume":"341","author":"Garcia","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2013.12.003_bib0425","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1086\/318530","article-title":"Perinatal transmission of human immunodeficiency virus type1 by pregnant women with RNA virus loads <1000 copies\/ml","volume":"183","author":"Ioannidis","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2013.12.003_bib0430","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0140-6736(03)14341-3","article-title":"Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial","volume":"362","author":"Jackson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.eimc.2013.12.003_bib0435","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1097\/00002030-200312050-00015","article-title":"Drug resistance is uncommon in pregnant women with low viral loads taking zidovudine monotherapy to prevent perinatal HIV transmission","volume":"17","author":"Larbalestier","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2013.12.003_bib0440","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1097\/QAD.0b013e328311d16f","article-title":"Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen","volume":"22","author":"Fox","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2013.12.003_bib0445","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","article-title":"Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment","volume":"331","author":"Connor","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2013.12.003_bib0450","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/jama.288.2.189","article-title":"Two-dose intrapartum\/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: A randomized trial","volume":"288","author":"Dorenbaum","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.eimc.2013.12.003_bib0455","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/QAD.0b013e3282f9b67a","article-title":"Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006","volume":"22","author":"Townsend","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2013.12.003_bib0460","doi-asserted-by":"crossref","DOI":"10.1097\/QAD.0b013e32834cdb71","article-title":"Safety of efavirenz in the first trimester of pregnancy: An updated systematic review and meta-analysis","volume":"25","author":"Ford","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2013.12.003_bib0465","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1310\/hct1106-303","article-title":"Treatment change in pregnancy is a significant risk factor for detectable HIV-1 RNA in plasma at end of pregnancy","volume":"11","author":"Floridia","year":"2010","journal-title":"HIV Clin Trials"},{"key":"10.1016\/j.eimc.2013.12.003_bib0470","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/00126334-200404150-00014","article-title":"Hepatotoxicity associated with nevirapine use","volume":"35","author":"Baylor","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2013.12.003_bib0475","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/QAD.0b013e3283428cbe","article-title":"First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: A cost-effectiveness analysis of the OCTANE trial","volume":"25","author":"Ciaranello","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2013.12.003_bib0480","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1056\/NEJMoa0907736","article-title":"Antiretroviral regimens in pregnancy and breast-feeding in Botswana","volume":"362","author":"Shapiro","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2013.12.003_bib0485","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/QAI.0b013e3181d6c9ed","article-title":"Lopinavir tablet pharmacokinetics with an increased dose during pregnancy","volume":"54","author":"Best","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2013.12.003_bib0490","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1468-1293.2011.00927.x","article-title":"Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV infected pregnant women","volume":"12","author":"Conradie","year":"2011","journal-title":"HIV Med"},{"key":"10.1016\/j.eimc.2013.12.003_bib0495","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/QAI.0b013e31820fd093","article-title":"Atazanavir pharmacokinetics with and without tenofovir during pregnancy","volume":"56","author":"Mirochnick","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2013.12.003_bib0500","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/QAD.0b013e32833653b2","article-title":"Use of darunavir\/ritonavir once daily in treatment-naive pregnant woman: pharmacokinetics, compartmental exposure, efficacy and safety","volume":"24","author":"Ivanovic","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2013.12.003_bib0505","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3851\/IMP1558","article-title":"Use of newer antiretroviral agents, darunavir and etravirine with or without raltegravir, in pregnancy: A report of two cases","volume":"15","author":"Jaworsky","year":"2010","journal-title":"Antivir Ther"},{"key":"10.1016\/j.eimc.2013.12.003_bib0510","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1097\/QAD.0b013e32833d8a50","article-title":"High neonatal concentrations of raltegravir following transplacental transfer in HIV-1 positive pregnant women","volume":"24","author":"McKeown","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2013.12.003_bib0515","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1093\/jac\/dkq264","article-title":"Rapid HIV-RNA decline following addition of raltegravir and tenofovir to ongoing highly active antiretroviral therapy in a woman presenting with high-level HIV viraemia at week 38 of pregnancy","volume":"65","author":"Pinnetti","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2013.12.003_bib0520","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1258\/ijsa.2011.010469","article-title":"Raltegravir in pregnancy: A case series presentation","volume":"22","author":"Taylor","year":"2011","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.eimc.2013.12.003_bib0525","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0140-6736(02)08214-4","article-title":"Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): A randomised, double-blind, placebo-controlled trial","volume":"359","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.eimc.2013.12.003_bib0530","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.clp.2010.08.012","article-title":"Issues of prematurity and HIV infection","volume":"37","author":"Mirpuri","year":"2010","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.eimc.2013.12.003_bib0535","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/GRF.0b013e318217d7a6","article-title":"Herpes Simplex and HIV Infections and Preterm PROM","volume":"54","author":"Ehsanipoor","year":"2011","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.eimc.2013.12.003_bib0540","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1468-1293.2009.00800.x","article-title":"Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: Changing practices in Western Europe","volume":"11","year":"2010","journal-title":"HIV medicine"},{"key":"10.1016\/j.eimc.2013.12.003_bib0545","unstructured":"Royal College of Obstetricians and Gynaecologists. Preterm Labour, Tocolytic Drugs. Green Top Guideline n.\u00b0 1B. February 2011."},{"key":"10.1016\/j.eimc.2013.12.003_bib0550","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0020-7292(03)00123-1","article-title":"Duration of ruptured membranes and extended labor are risk factors for HIV transmission","volume":"82","author":"Garcia-Tejedor","year":"2003","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.eimc.2013.12.003_bib0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2012.10.862","article-title":"Duration of membrane rupture and risk of perinatal transmission of HIV-1 in the era of combination antiretroviral therapy","volume":"207","author":"Cotter","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.eimc.2013.12.003_bib0560","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/AOG.0b013e3181e8f38a","article-title":"Model of delivery and infants respiratory morbidity among infants born to HIV-infected women","volume":"116","author":"Livingston","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.eimc.2013.12.003_bib0565","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1471-0528.2006.01183.x","article-title":"The AmRo Study: Pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery","volume":"114","author":"Boer","year":"2007","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.eimc.2013.12.003_bib0570","unstructured":"Puerperio normal y patol\u00f3gico. Protocolos de la Sociedad Espa\u00f1ola de Ginecolog\u00eda y Obstetricia (SEGO) [consultado 5 Sep 2011]. Disponible en: http:\/\/www.prosego.com\/docs\/protocolos\/PDF_Protocolo_puerperio.pdf"},{"issue":"2 Pt 1","key":"10.1016\/j.eimc.2013.12.003_bib0575","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/01.AOG.0000275263.81272.fc","article-title":"Perioperative morbidity and mortality among human immunodeficiency virus infected women undergoing cesarean delivery","volume":"110","author":"Louis","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.eimc.2013.12.003_bib0580","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00404-002-0374-8","article-title":"Post-operative complications after caesarean section in HIV-infected women","volume":"268","author":"Ferrero","year":"2003","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.eimc.2013.12.003_bib0585","doi-asserted-by":"crossref","first-page":"79512","DOI":"10.1155\/IDOG\/2006\/79512","article-title":"Postpartum morbidity associated with advanced HIV disease","volume":"2006","author":"Louis","year":"2006","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.eimc.2013.12.003_bib0590","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/MBC.0b013e3282f38c23","article-title":"Venous thromboembolism in HIV-positive women during puerperium: A case series","volume":"19","author":"Jansen","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.eimc.2013.12.003_bib0595","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijgo.2007.06.053","article-title":"Morbidity in the first year postpartum among HIV-infected women in Kenya","volume":"100","author":"Chersich","year":"2008","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.eimc.2013.12.003_bib0600","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/AOG.0b013e3181c6f8a4","article-title":"Cervical cytology screening","volume":"114","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.eimc.2013.12.003_bib0605","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.contraception.2010.11.001","article-title":"Postpartum contraceptive preferences of HIV-infected women in the era of highly active antiretroviral therapy (HAART) and scheduled cesarean deliveries","volume":"84","author":"Tuuli","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.eimc.2013.12.003_bib0610","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijgo.2009.08.014","article-title":"Resumption of sexual activity and regular menses after childbirth among women infected with HIV in Malawi","volume":"108","author":"Makanani","year":"2010","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.eimc.2013.12.003_bib0615","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/01.OLQ.0000086617.41012.14","article-title":"Dual contraceptive method use for pregnancy and disease prevention among HIV-infected and HIV-uninfected women: The importance of an event-level focus for promoting safer sexual behaviors","volume":"30","author":"Wilson","year":"2003","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.eimc.2013.12.003_bib0620","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3109\/13625180903340584","article-title":"Improved access increases postpartum uptake of contraceptive implants among HIV-positive women in Rwanda","volume":"14","author":"Dhont","year":"2009","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.eimc.2013.12.003_bib0625","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.2105\/AJPH.2005.067744","article-title":"Physical and sexual violence during pregnancy and after delivery: A prospective multistate study of women with or at risk for HIV infection","volume":"96","author":"Koenig","year":"2006","journal-title":"Am J Public Health"},{"key":"10.1016\/j.eimc.2013.12.003_bib0630","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1542-2011.2011.00029.x","article-title":"Defining male support during and after pregnancy from the perspective of HIV-positive and HIV-negative women in Durban, South Africa","volume":"56","author":"Maman","year":"2011","journal-title":"J Midwifery Womens Health"},{"key":"10.1016\/j.eimc.2013.12.003_bib0635","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00737-010-0162-6","article-title":"Prevalence and incidence of postnatal depression: What can systematic reviews tell us?","volume":"13","author":"Mann","year":"2010","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.eimc.2013.12.003_bib0640","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1542\/peds.2010-2348","article-title":"Clinical report\u2014Incorporating recognition and management of perinatal and postpartum depression into pediatric practice","volume":"126","author":"Marian","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.eimc.2013.12.003_bib0645","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4067\/S0716-10182010000100011","article-title":"Prevalencia, factores de riesgo y manejo de la depresi\u00f3n en pacientes con infecci\u00f3n por VIH: revisi\u00f3n de la literatura","volume":"27","author":"Wolff","year":"2010","journal-title":"Rev Chil Infect"},{"key":"10.1016\/j.eimc.2013.12.003_bib0650","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00737-008-0023-8","article-title":"HIV-infected mothers\u2019 perceptions of uncertainty, stress, depression and social support during HIV viral testing of their infants","volume":"11","author":"Shannon","year":"2008","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.eimc.2013.12.003_bib0655","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1089\/jwh.2010.2012","article-title":"Postnatal depression by HIV status among women in Zimbabwe","volume":"19","author":"Chibanda","year":"2010","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.eimc.2013.12.003_bib0660","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1310\/hct1201-9","article-title":"Postpartum viral load rebound in HIV-1-infected women treated with highly active antiretroviral therapy: AIDS Clinical Trials Group Protocol A5150","volume":"12","author":"Sha","year":"2011","journal-title":"HIV Clin Trials"},{"key":"10.1016\/j.eimc.2013.12.003_bib0665","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijgo.2009.09.014","article-title":"Predictors of postpartum viral load rebound in a cohort of HIV-infected Brazilian women","volume":"108","author":"Cavallo","year":"2010","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.eimc.2013.12.003_bib0670","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/apc.2009.0283","article-title":"Postpartum discontinuation of antiretroviral therapy and risk of maternal AIDS-defining events, non-AIDS-defining events, and mortality among a cohort of HIV-1 infected women in the United States","volume":"24","author":"Melekhin","year":"2010","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.eimc.2013.12.003_bib0675","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/QAI.0b013e31817bbe80","article-title":"Adherence to antiretrovirals among US women during and after pregnancy","volume":"48","author":"Bardeguez","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2013.12.003_bib0680","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1080\/09540120701767208","article-title":"Adherence to antiretroviral treatment among pregnant and postpartum HIV-infected women","volume":"20","author":"Mellins","year":"2008","journal-title":"AIDS Care"},{"key":"10.1016\/j.eimc.2013.12.003_bib0685","unstructured":"Recomendaciones de la Secretar\u00eda del Plan Nacional sobre el Sida (SPNS), el Grupo de Estudio de Sida (GeSida\/SEIMC), la Sociedad Espa\u00f1ola de Ginecolog\u00eda y Obstetricia (SEGO) y la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda (AEP) para el seguimiento de la infecci\u00f3n por el VIH con relaci\u00f3n a la reproducci\u00f3n, el embarazo y la prevenci\u00f3n de la transmisi\u00f3n vertical. Junio de 2007 [consultado 4 Nov 2013]. Disponible en: http:\/\/www.mspsi.es\/ciudadanos\/enfLesiones\/enfTransmisibles\/sida\/docs\/Recomendaciones_VIH_embarazoyprevencion_Junio2007.pdf"},{"key":"10.1016\/j.eimc.2013.12.003_bib0690","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1468-1293.2008.00619.x","article-title":"British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008","volume":"9","author":"De Ruiter","year":"2008","journal-title":"HIV Med"},{"key":"10.1016\/j.eimc.2013.12.003_bib0695","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jpeds.2011.06.053","article-title":"Agence Nationale de Recherche sur le SIDA et les H\u00e9patites Virales. French Perinatal Cohort. Performance of HIV-1 DNA or HIV-1 RNA tests for early diagnosis of perinatal HIV-1 infection during anti-retroviral prophylaxis","volume":"160","author":"Burgard","year":"2012","journal-title":"J Pediatr"},{"key":"10.1016\/j.eimc.2013.12.003_bib0700","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1542\/peds.2008-3076","article-title":"Evaluation and management of the infant exposed to HIV-1 in the United States","volume":"123","author":"Havens","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.eimc.2013.12.003_bib0705","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1542\/peds.2007-2951","article-title":"Diagnosis of HIV-1 infection in children younger than 18 months in the United States","volume":"120","author":"Read","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.eimc.2013.12.003_bib0710","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1056\/NEJMoa1108275","article-title":"Three postpartum antiretroviral regimens to prevent intrapartum HIV infection","volume":"366","author":"Nielsen-Saines","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2013.12.003_bib0715","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3109\/00365548.2011.567392","article-title":"Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations 2010","volume":"43","author":"Nav\u00e9r","year":"2011","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.eimc.2013.12.003_bib0720","first-page":"655","article-title":"Nevirapine plasma concentrations in premature infants exposed to single-dose nevirapine for prevention of mother-to-child transmission of HIV-1","volume":"101","author":"Mugabo","year":"2011","journal-title":"S Afr Med J"},{"key":"10.1016\/j.eimc.2013.12.003_bib0725","series-title":"18th Conference on Retrovirus and Opportunistic Infections","article-title":"Neonatal toxicity of kaletra oral solution: LPV, ethanol or prophylene glycol?","author":"Boxwell","year":"2011"},{"key":"10.1016\/j.eimc.2013.12.003_bib0730","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1468-1293.2008.00639.x","article-title":"Spanish Cohort of HIV-infected Mother-Infant Pairs. Gestational diabetes mellitus in a cohort of HIV-1 infected women","volume":"9","author":"Gonz\u00e1lez-Tom\u00e9","year":"2008","journal-title":"HIV Med"},{"key":"10.1016\/j.eimc.2013.12.003_bib0735","unstructured":"Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, et al. Reduction of maternal-infant transmission of Human Immunodeficiency Virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group 076 Study Group N Eng J Med 1994; 331:1173\u201380."},{"key":"10.1016\/j.eimc.2013.12.003_bib0740","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1097\/00002030-200410210-00005","article-title":"Levels and pattern of neutrophil cell counts over the first 8 years of life in children of HIV-1-infected mothers","volume":"18","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2013.12.003_bib0745","doi-asserted-by":"crossref","first-page":"e598","DOI":"10.1542\/peds.2004-0955","article-title":"Hyperlactatemia in human immunodeficiency virus-uninfected infants who are exposed to antiretrovirals","volume":"114","author":"Noguera","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.eimc.2013.12.003_bib0750","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1001\/jama.2011.100","article-title":"Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants","volume":"305","author":"Jones","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.eimc.2013.12.003_bib0755","unstructured":"Recomendaciones CEVIHP\/SEIP\/AEP\/PNS respecto al tratamiento antirretroviral en ni\u00f1os y adolescentes infectados por el virus de la inmunodeficiencia humana (VIH). Marzo 2008 [consultado 23 Oct 2013]. Disponible en: www.seipweb.es"},{"issue":"RR-11","key":"10.1016\/j.eimc.2013.12.003_bib0760","first-page":"1","article-title":"Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children","volume":"58","year":"2009","journal-title":"MMWR"},{"key":"10.1016\/j.eimc.2013.12.003_bib0765","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1001\/jama.283.9.1167","article-title":"Effect of breastfeeding and formula feeding on transmission of HIV-1: A randomized clinical trial","volume":"283","author":"Nduati","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.eimc.2013.12.003_bib0770","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1086\/420834","article-title":"Late postnatal transmission of HIV-1 in breast-fed children: An individual patient data meta-analysis","volume":"189","author":"Coutsoudis","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2013.12.003_bib0775","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJMoa0801941","article-title":"Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission","volume":"359","author":"Kumwenda","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2013.12.003_bib0780","first-page":"360","article-title":"Recommendations issued by the Spanish Society of Pediatric Infectious Diseases for the follow-up of the child exposed to the human immunodeficiency virus and to antirretroviral drugs during pregnancy and the neonatal period","volume":"76","author":"Noguera Julian","year":"2012","journal-title":"An Pediatr (Bar)"},{"key":"10.1016\/j.eimc.2013.12.003_bib0785","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1086\/512815","article-title":"Impact of maternal HIV coinfection on the vertical transmission of hepatitis C virus: A meta-analysis","volume":"44","author":"Polis","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2013.12.003_bib0790","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1086\/367704","article-title":"Increased risk of mother-to-infant transmission of hepatitis C virus by intrapartum infantile exposure to maternal blood","volume":"187","author":"Steininger","year":"2003","journal-title":"J Infect Dis"},{"issue":"Suppl","key":"10.1016\/j.eimc.2013.12.003_bib0795","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S1665-2681(19)31731-4","article-title":"The management of HCV-infected pregnant women","volume":"9","author":"Valladares","year":"2010","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.eimc.2013.12.003_bib0800","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1086\/497695","article-title":"A significant sex\u2014but not elective cesarean section\u2014effect on mother-to-child transmission of hepatitis C virus infection","volume":"192","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2013.12.003_bib0805","first-page":"CD005546","article-title":"Caesarean section versus vaginal delivery for preventing mother to infant hepatitis C virus transmission","author":"McIntyre","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eimc.2013.12.003_bib0810","first-page":"371","article-title":"Effects of mode of delivery and infant feeding on the risk of mother-to-child transmission of hepatitis C virus. European Paediatric Hepatitis C Virus Network","volume":"108","year":"2001","journal-title":"BJOG"},{"key":"10.1016\/j.eimc.2013.12.003_bib0815","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00404-010-1588-9","article-title":"Effect of cesarean section on the risk of perinatal transmission of hepatitis C virus from HCV-RNA+\/HIV-mothers: A meta-analysis","volume":"283","author":"Ghamar Chehreh","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.eimc.2013.12.003_bib0820","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1034\/j.1600-0412.2003.00107.x","article-title":"Prospective study of mother-to-infant transmission of hepatitis C virus: A 10-year survey (1990-2000)","volume":"82","author":"Ferrero","year":"2003","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.eimc.2013.12.003_bib0825","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/jmv.21437","article-title":"Perinatal transmission of hepatitis C virus infection","volume":"81","author":"Indolfi","year":"2009","journal-title":"J Med Virol"},{"key":"10.1016\/j.eimc.2013.12.003_bib0830","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1093\/infdis\/170.6.1418","article-title":"Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load","volume":"170","author":"Burk","year":"1994","journal-title":"J Infect Dis"},{"issue":"RR-8","key":"10.1016\/j.eimc.2013.12.003_bib0835","first-page":"1","article-title":"Recommendations for identification and public health management of persons with chronic hepatitis B virus infection","volume":"57","author":"Weinbaum","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.eimc.2013.12.003_bib0840","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF01584356","article-title":"Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study","volume":"17","author":"Hofer","year":"1998","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.eimc.2013.12.003_bib0845","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/hep.510300525","article-title":"Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients","volume":"30","author":"Benhamou","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.eimc.2013.12.003_bib0850","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1056\/NEJMoa067710","article-title":"The HBV drug entecavir \u2014 effects on HIV-1 replication and resistance","volume":"356","author":"McMahon","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2013.12.003_bib0855","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1212\/01.wnl.0000180575.77021.c4","article-title":"The reproductive effects of beta interferon therapy in pregnancy: A longitudinal cohort","volume":"65","author":"Boskovic","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.eimc.2013.12.003_bib0860","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1001\/jama.1987.03390190090026","article-title":"Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission","volume":"257","author":"Stevens","year":"1987","journal-title":"JAMA"},{"key":"10.1016\/j.eimc.2013.12.003_bib0865","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.3748\/wjg.v9.i7.1501","article-title":"Interruption of HBV intrauterine transmission: A clinical study","volume":"9","author":"Li","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.eimc.2013.12.003_bib0870","unstructured":"Bernaola E, Gim\u00e9nez-S\u00e1nchez F, Baca M, de Juan F, D\u00edez-Domingo J, Garc\u00e9s M, et al. Calendario de Vacunaci\u00f3n de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda: recomendaciones 2006 [consultado 4 Oct 2013]. Disponible en: http:\/\/www.vacunasaep.org\/"},{"key":"10.1016\/j.eimc.2013.12.003_bib0875","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1542\/peds.66.6.980","article-title":"Congenital tuberculosis: Critical reappraisal of clinical findings and diagnostic procedures","volume":"66","author":"Hageman","year":"1980","journal-title":"Pediatrics"},{"key":"10.1016\/j.eimc.2013.12.003_bib0880","unstructured":"Treatment of tuberculosis: Guidelines for national programmes, 3rd ed. WHO\/CDS\/TB\/2003.313. World Health Organization, Geneva, Switzerland 2003 [consultado 31 Oct 2013]. Disponible en: http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241547833_eng.pdf"},{"key":"10.1016\/j.eimc.2013.12.003_bib0885","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1097\/01.AOG.0000216197.26783.b5","article-title":"Antibiotic use in pregnancy and lactation: What is and is not known about teratogenic and toxic risks","volume":"107","author":"Nahum","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.eimc.2013.12.003_bib0890","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1086\/606056","article-title":"Pharmacokinetic evaluation of rifabutin in combination with lopinavir-ritonavir in patients with HIV infection and active tuberculosis","volume":"49","author":"Boulanger","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2013.12.003_bib0895","unstructured":"CDC. Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis [online]. 2007 [consultado 6 Nov 2013]. Disponible en: http:\/\/www.cdc.gov\/tb\/TB_HIV_Drugs\/default.htm"},{"key":"10.1016\/j.eimc.2013.12.003_bib0900","first-page":"360","article-title":"Safety and efficacy of nevirapine- and efavirenz-based antiretroviral treatment in adults treated for TB-HIV co-infection in Botswana","volume":"13","author":"Shipton","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.eimc.2013.12.003_bib0905","unstructured":"Elk Grove Village. Tuberculosis. En: Pickering L, editor. American Academy of Pediatrics. Tuberculosis. En: Red Book: 2009 Report of the Committee on Infectious Diseases. 2009: 680."},{"issue":"RR-6","key":"10.1016\/j.eimc.2013.12.003_bib0910","first-page":"1","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society","volume":"49","year":"2000","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.eimc.2013.12.003_bib0915","first-page":"283","article-title":"Persistence of nevirapine exposure during the postpartum period after intrapartum single-dose nevirapine in addition to zidovudine prophylaxis for the prevention of mother-to-child transmission of HIV-1","volume":"38","author":"Cressey","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2013.12.003_bib0920","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1086\/341300","volume":"186","author":"Cunningham","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2013.12.003_bib0925","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/QAD.0b013e32832e5303","article-title":"Postpartum antiretroviral drug resistance in HIV-1-infected women receiving pregnancy-limited antiretroviral therapy","volume":"24","author":"Paredes","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2013.12.003_bib0930","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1097\/00002030-199817000-00009","article-title":"Selective vertical transmission of HIV-1 antiretroviral resistance mutations","volume":"12","author":"Colgrove","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2013.12.003_bib0935","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00001432-200102000-00005","article-title":"Implications of antiretroviral resistance on viral fitness","volume":"14","author":"Nijhuis","year":"2001","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.eimc.2013.12.003_bib0940","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00126334-200303010-00008","article-title":"Prevalence of genotypic drug resistance among a cohort of HIV-infected newborns","volume":"32","author":"Parker","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2013.12.003_bib0945","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/01.qai.0000225871.87456.e7","article-title":"Prevalence of drug-resistance mutations and non-subtype B strains among HIV-infected infants from New York State","volume":"42","author":"Karchava","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2013.12.003_bib0950","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/QAI.0b013e31814b97e4","article-title":"Effectiveness of repeat single-dose nevirapine for prevention of mother-to-child transmission of HIV-1 in repeat pregnancies in Uganda","volume":"46","author":"McConnell","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2013.12.003_bib0955","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/QAI.0b013e318050d652","article-title":"Transmission rates in consecutive pregnancies exposed to single-dose nevirapine in Soweto, South Africa and Abidjan, Cote d\u2019Ivoire","volume":"45","author":"Martinson","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2013.12.003_bib0960","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJM199811123392001","article-title":"Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus","volume":"339","author":"Wade","year":"1998","journal-title":"N Engl J Med"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X1300390X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X1300390X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T19:21:33Z","timestamp":1716492093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X1300390X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":192,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0213005X1300390X"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2013.12.003","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Documento de consenso para el seguimiento de la infecci\u00f3n por el virus de la inmunodeficiencia humana en relaci\u00f3n con la reproducci\u00f3n, el embarazo, el parto y la profilaxis de la transmisi\u00f3n vertical del ni\u00f1o expuesto","name":"articletitle","label":"Article Title"},{"value":"Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2013.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Espa\u00f1a, S.L. y Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. All rights reserved.","name":"copyright","label":"Copyright"}]}}